Concourse Financial Group Securities, Inc. Panbela Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$0.43 - $6.87 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.46 - $1.57 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$1.24 - $2.38 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$1.24 - $2.38 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$0.22 - $7.13 $0 - $0	0 New	0 $0

Q1 2023 May 15, 2023	BUY	$0.08 - $3.36 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$0.07 - $0.16 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$0.24 - $1.4 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$0.61 - $2.1 $0 - $0	0 New	0 $0

Others Institutions Holding PBLA

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Panbela Therapeutics, Inc.

Ticker PBLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,774,000
Market Cap $7.48M
Description
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer...

More about PBLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account